Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1625 of 1631 entries
View as:

Data on Oral Contraceptives Compliance in Non Stop Regimen

Phase: N/A Priority: Normal
NCT ID: NCT01185678 Org: User:
Start: 05/31/10 End: 11/30/10 Due: 11/30/11

Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00668109 Org: User:
Start: 12/31/03 End: 06/30/04 Due: 06/30/05

Sun Protection Factor Assay (SPF Assay 201/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02930772 Org: User:
Start: 10/12/16 End: 11/03/16 Due: 11/03/17

Hemodynamic and Echocardiographic Assessment of Riociguat Effects on Myocardial Wall Contractility and Relaxation Kinetics

Phase: N/A Priority: Normal
NCT ID: NCT01065051 Org: User:
Start: 11/30/10 End: 01/31/11 Due: 01/31/12

Efficacy of Dexpanthenol in Thermic Erythema

Phase: N/A Priority: Normal
NCT ID: NCT00839462 Org: User:
Start: 09/30/07 End: 09/30/07 Due: 09/30/08

A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema

Phase: N/A Priority: Normal
NCT ID: NCT02850263 Org: User:
Start: 07/05/16 End: 11/23/20 Due: 11/23/21

Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT00657839 Org: User:
Start: 10/31/05 End: 06/30/06 Due: 06/30/07

Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination

Phase: N/A Priority: Normal
NCT ID: NCT01585870 Org: User:
Start: 07/31/12 End: 09/30/15 Due: 09/30/16

A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03517930 Org: User:
Start: 04/17/18 End: 07/20/18 Due: 07/20/19

Study to Learn More About the Potential of Antifungal Cream V61-044 Containing Trolamine to Cause Irritant Reaction of the Skin to Ultra Violet Light in Healthy Human Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04531527 Org: User:
Start: 06/24/13 End: 06/28/13 Due: 06/28/14

To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development

Phase: N/A Priority: Normal
NCT ID: NCT02490774 Org: User:
Start: 06/22/15 End: 07/22/16 Due: 07/22/17

Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist

Phase: N/A Priority: Normal
NCT ID: NCT00744939 Org: User:
Start: 11/30/08 End: 11/30/13 Due: 11/30/14

Sun Protection Factor Assay (SPF Assay 205/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02936557 Org: User:
Start: 10/26/16 End: 11/17/16 Due: 11/17/17

First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)

Phase: N/A Priority: Normal
NCT ID: NCT05099172 Org: User:
Start: 10/25/21 End: 12/31/26 Due: 12/31/27

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries

Phase: N/A Priority: Normal
NCT ID: NCT00309075 Org: User:
Start: 12/31/03 End: 11/30/04 Due: 11/30/05

Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03330288 Org: User:
Start: 11/20/17 End: 07/13/20 Due: 07/13/21

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

Phase: N/A Priority: Normal
NCT ID: NCT04477707 Org: User:
Start: 07/23/20 End: 06/25/21 Due: 06/25/22

A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT03424135 Org: User:
Start: 03/02/18 End: 04/04/18 Due: 04/04/19

Effect of BAY 43-9006 (Sorafenib) on Cardiovascular Safety Parameters in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00259129 Org: User:
Start: 08/31/05 End: 03/31/08 Due: 03/31/09

Safety of Gadovist in Renally Impaired Patients

Phase: N/A Priority: Normal
NCT ID: NCT00828737 Org: User:
Start: 12/31/08 End: 01/31/15 Due: 01/31/16

18615 - Sun Protection Factor Assay

Phase: N/A Priority: Normal
NCT ID: NCT02756988 Org: User:
Start: 10/19/15 End: 10/21/15 Due: 10/21/16

Combination With Gemcitabine in Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01251640 Org: User:
Start: 01/01/11 End: 08/01/13 Due: 08/01/14

ZK283197 for Treatment of Vasomotor Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT00537836 Org: User:
Start: 10/31/07 End: 12/31/08 Due: 12/31/09

Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache

Phase: N/A Priority: Normal
NCT ID: NCT01464983 Org: User:
Start: 01/31/04 End: 08/31/04 Due: 08/31/05

Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the Drug

Phase: N/A Priority: Normal
NCT ID: NCT04095273 Org: User:
Start: 09/30/19 End: 04/11/23 Due: 04/11/24